About Aflac

Since 1995, Aflac’s support has helped make the Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta one of the leading programs in the country.

To date, the insurance provider and its Aflac Field Force have contributed more than $110 million to the Aflac Cancer Center, making the company the largest corporate supporter of Children’s.

"Thanks to Aflac’s generous support, the Aflac Cancer Center has the resources to offer patients and their families a team of specialized pediatric caregivers who have an emphasis on high-quality care and dedicated research. We are able to provide a source of strength and create a place of hope for children," said William G. Woods, M.D., Emeritus Director for the Aflac Cancer and Blood Disorders Center.

The Aflac Family, including employees, executives and the Field Force have embraced the Aflac Cancer Center as the company’s largest philanthropy. 

Aflac’s financial contributions have been used to fund:

  • Inpatient and outpatient facilities at Egleston and Scottish Rite hospitals
  • A state-of-the-art pediatric research building
  • Research for cures for childhood cancers and blood disorders
  • Endowments for the family support team and fellowship program, endowed chairs for the chief medical officer and leaders in developmental therapeutics, cancer survivorship and sickle cell disease

Aflac has set the standard for a true philanthropic partnership by which all others should be measured. Children’s thanks Aflac for their continued support in the fight against childhood cancer and blood disorders.

Ongoing support

The following special events and programs are sponsored by Aflac and benefit the Aflac Cancer and Blood Disorders Center and its patients.

  • Aflac bingo: One Saturday a month, Aflac employee volunteers visit the Aflac Cancer Center and play bingo with the patients.
  • Braves Night: In an annual tradition that began in 1995, more than 100 patients and their families meet Atlanta Braves players, get autographs and watch a game.